Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.
Saved in:
| Title: | Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. |
|---|---|
| Authors: | Klonoff DC (AUTHOR), Buse JB (AUTHOR), Nielsen LL (AUTHOR), Guan X (AUTHOR), Bowlus CL (AUTHOR), Holcombe JH (AUTHOR), Wintle ME (AUTHOR), Maggs DG (AUTHOR), Klonoff, David C1 (AUTHOR), Buse, John B (AUTHOR), Nielsen, Loretta L (AUTHOR), Guan, Xuesong (AUTHOR), Bowlus, Christopher L (AUTHOR), Holcombe, John H (AUTHOR), Wintle, Matthew E (AUTHOR), Maggs, David G (AUTHOR) |
| Source: | Current Medical Research & Opinion. Jan2008, Vol. 24 Issue 1, p275-286. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
